Clinical Trials List
2012-06-01 - 2014-06-30
Phase II
Study ended6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 黃建達 Division of Thoracic Medicine
- Chun-Hua Wang Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- kang-Yun LEE Division of Thoracic Medicine
- Chih-Teng Yu Division of Thoracic Medicine
- Fu-Tsai Chung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Chao-Hua Chiu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Chih-Jen Yang Division of Thoracic Medicine
- Jen-Yu Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Chong-Jen Yu Division of Thoracic Medicine
- 廖唯昱 Division of Thoracic Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 陳冠宇 Division of Thoracic Medicine
- JIN-YUAN SHIH Division of Thoracic Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
260 participants
